Sumitomo Pharma Co., Ltd. (DNPUF)

Market Cap	6.24B
Revenue (ttm)	3.01B
Net Income (ttm)	1.05B
Shares Out	n/a
EPS (ttm)	2.63
PE Ratio	5.97
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	371
Average Volume	1,547
Open	16.60
Previous Close	n/a
Day's Range	16.60 - 16.74
52-Week Range	3.44 - 18.88
Beta	0.54
RSI	79.95
Earnings Date	Jan 30, 2026

About Sumitomo Pharma

Sumitomo Pharma Co., Ltd. engages in manufacture, purchase, and sale of pharmaceutical products for medical treatment in Japan, North America, and Asia. The company offers therapeutic agents for parkinson’s disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. It also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, the company offers veterinary drugs, medical devices, etc. It h...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1897
• Employees: 3,832
• Stock Exchange: OTCMKTS
• Ticker Symbol: DNPUF

Financial Performance

Financial numbers in JPY